Tyrosine phosphorylation of RNA Polymerase II CTD is associated with antisense promoter transcription and active enhancers in mammalian cells

  1. Nicolas Descostes
  2. Martin Heidemann
  3. Lionel Spinelli
  4. Roland Schüller
  5. Muhammad A Maqbool
  6. Romain Fenouil
  7. Frederic Koch
  8. Charlène Innocenti
  9. Marta Gut
  10. Ivo Gut
  11. Dirk Eick
  12. Jean-Christophe Andrau  Is a corresponding author
  1. Centre d'Immunologie de Marseille Luminy, Université Aix-Marseille, France
  2. Helmholtz Center Munich, Center of Integrated Protein Science Munich (CIPSM), Germany
  3. Centre d'Immunologie de Marseille-Luminy, Université Aix-Marseille, France
  4. Institut de Génétique Moléculaire de Montpellier (IGMM), CNRS-UMR, France
  5. Max Planck Institute for Molecular Genetics, Germany
  6. Institut de Génomique Fonctionnelle, France
  7. Centre Nacional D'Anàlisi Genòmica, Spain
  8. Insitut de Génétique Moléculaire de Montpellier (IGMM), CNRS-UMR, France

Abstract

In mammals, the carboxy-terminal domain (CTD) of RNA polymerase (Pol) II consists of 52 conserved heptapeptide repeats containing the consensus sequence Tyr1-Ser2-Pro3-Thr4-Ser5-Pro6-Ser7. Post-translational modifications of the CTD coordinate the transcription cycle and various steps of mRNA maturation. Here we describe Tyr1 phosphorylation (Tyr1P) as a hallmark of promoter (5' associated) Pol II in mammalian cells, in contrast to what was described in yeast. Tyr1P is predominantly found in antisense orientation at promoters but is also specifically enriched at active enhancers. Mutation of Tyr1 to phenylalanine (Y1F) prevents the formation of the hyper-phosphorylated Pol IIO form, induces degradation of Pol II to the truncated Pol IIB form and results in a lethal phenotype. Our results suggest that Tyr1P has evolved specialized and essential functions in higher eukaryotes associated with antisense promoter and enhancer transcription, and Pol II stability.

Article and author information

Author details

  1. Nicolas Descostes

    Centre d'Immunologie de Marseille Luminy, Université Aix-Marseille, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  2. Martin Heidemann

    Helmholtz Center Munich, Center of Integrated Protein Science Munich (CIPSM), Munich, Germany
    Competing interests
    The authors declare that no competing interests exist.
  3. Lionel Spinelli

    Centre d'Immunologie de Marseille-Luminy, Université Aix-Marseille, Marseilles, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Roland Schüller

    Helmholtz Center Munich, Center of Integrated Protein Science Munich (CIPSM), Munich, Germany
    Competing interests
    The authors declare that no competing interests exist.
  5. Muhammad A Maqbool

    Institut de Génétique Moléculaire de Montpellier (IGMM), CNRS-UMR, Montpellier, France
    Competing interests
    The authors declare that no competing interests exist.
  6. Romain Fenouil

    Centre d'Immunologie de Marseille-Luminy, Université Aix-Marseille, Marseilles, France
    Competing interests
    The authors declare that no competing interests exist.
  7. Frederic Koch

    Max Planck Institute for Molecular Genetics, Berlin, Germany
    Competing interests
    The authors declare that no competing interests exist.
  8. Charlène Innocenti

    Institut de Génomique Fonctionnelle, Montpellier, France
    Competing interests
    The authors declare that no competing interests exist.
  9. Marta Gut

    Centre Nacional D'Anàlisi Genòmica, Barcelona, Spain
    Competing interests
    The authors declare that no competing interests exist.
  10. Ivo Gut

    Centre Nacional D'Anàlisi Genòmica, Barcelona, Spain
    Competing interests
    The authors declare that no competing interests exist.
  11. Dirk Eick

    Helmholtz Center Munich, Center of Integrated Protein Science Munich (CIPSM), Munich, Germany
    Competing interests
    The authors declare that no competing interests exist.
  12. Jean-Christophe Andrau

    Insitut de Génétique Moléculaire de Montpellier (IGMM), CNRS-UMR, Montpellier, France
    For correspondence
    jean-christophe.andrau@igmm.cnrs.fr
    Competing interests
    The authors declare that no competing interests exist.

Copyright

© 2014, Descostes et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,936
    views
  • 607
    downloads
  • 77
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Nicolas Descostes
  2. Martin Heidemann
  3. Lionel Spinelli
  4. Roland Schüller
  5. Muhammad A Maqbool
  6. Romain Fenouil
  7. Frederic Koch
  8. Charlène Innocenti
  9. Marta Gut
  10. Ivo Gut
  11. Dirk Eick
  12. Jean-Christophe Andrau
(2014)
Tyrosine phosphorylation of RNA Polymerase II CTD is associated with antisense promoter transcription and active enhancers in mammalian cells
eLife 3:e02105.
https://doi.org/10.7554/eLife.02105

Share this article

https://doi.org/10.7554/eLife.02105

Further reading

    1. Chromosomes and Gene Expression
    2. Genetics and Genomics
    Hasiba Asma, Ellen Tieke ... Marc S Halfon
    Tools and Resources

    Annotation of newly sequenced genomes frequently includes genes, but rarely covers important non-coding genomic features such as the cis-regulatory modules—e.g., enhancers and silencers—that regulate gene expression. Here, we begin to remedy this situation by developing a workflow for rapid initial annotation of insect regulatory sequences, and provide a searchable database resource with enhancer predictions for 33 genomes. Using our previously developed SCRMshaw computational enhancer prediction method, we predict over 2.8 million regulatory sequences along with the tissues where they are expected to be active, in a set of insect species ranging over 360 million years of evolution. Extensive analysis and validation of the data provides several lines of evidence suggesting that we achieve a high true-positive rate for enhancer prediction. One, we show that our predictions target specific loci, rather than random genomic locations. Two, we predict enhancers in orthologous loci across a diverged set of species to a significantly higher degree than random expectation would allow. Three, we demonstrate that our predictions are highly enriched for regions of accessible chromatin. Four, we achieve a validation rate in excess of 70% using in vivo reporter gene assays. As we continue to annotate both new tissues and new species, our regulatory annotation resource will provide a rich source of data for the research community and will have utility for both small-scale (single gene, single species) and large-scale (many genes, many species) studies of gene regulation. In particular, the ability to search for functionally related regulatory elements in orthologous loci should greatly facilitate studies of enhancer evolution even among distantly related species.

    1. Chromosomes and Gene Expression
    Zulong Chen, Xin Wang ... Jessica K Tyler
    Research Article

    In response to DNA double-strand damage, ongoing transcription is inhibited to facilitate accurate DNA repair while transcriptional recovery occurs after DNA repair is complete. However, the mechanisms at play and the identity of the transcripts being regulated in this manner are unclear. In contrast to the situation following UV damage, we found that transcriptional recovery after ionizing radiation (IR) occurs in a manner independent of the HIRA histone chaperone. Sequencing of the nascent transcripts identified a programmed transcriptional response, where certain transcripts and pathways are rapidly downregulated after IR, while other transcripts and pathways are upregulated. Specifically, most of the loss of nascent transcripts occurring after IR is due to inhibition of transcriptional initiation of the highly transcribed histone genes and the rDNA. To identify factors responsible for transcriptional inhibition after IR in an unbiased manner, we performed a whole genome gRNA library CRISPR/Cas9 screen. Many of the top hits on our screen were factors required for protein neddylation. However, at short times after inhibition of neddylation, transcriptional inhibition still occurred after IR, even though neddylation was effectively inhibited. Persistent inhibition of neddylation blocked transcriptional inhibition after IR, and it also leads to cell cycle arrest. Indeed, we uncovered that many inhibitors and conditions that lead to cell cycle arrest in G1 or G2 phase also prevent transcriptional inhibition after IR. As such, it appears that transcriptional inhibition after IR occurs preferentially at highly expressed genes in cycling cells.